Efficacy of the new β-D-glucan measurement kit for diagnosing invasive fungal infections, as compared with that of four conventional kits.

<h4>Background</h4>Each of the currently available (1→3)-β-D-glucan (BDG) measurement kits follows a different measurement method and cut-off value. Comparisons of diagnostic performance for invasive fungal infections (IFIs) are desirable. Additionally, ecological considerations are beco...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yuuki Bamba, Kei Nagano, Hiroshi Moro, Hideyuki Ogata, Mariko Hakamata, Satoshi Shibata, Takeshi Koizumi, Nobumasa Aoki, Yasuyoshi Ohshima, Satoshi Watanabe, Takeshi Nakamura, Sugako Kobayashi, Yoshiki Hoshiyama, Toshiyuki Koya, Toshinori Takada, Toshiaki Kikuchi
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/70e651877f644db78bd88a7849765f8a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:70e651877f644db78bd88a7849765f8a
record_format dspace
spelling oai:doaj.org-article:70e651877f644db78bd88a7849765f8a2021-12-02T20:14:54ZEfficacy of the new β-D-glucan measurement kit for diagnosing invasive fungal infections, as compared with that of four conventional kits.1932-620310.1371/journal.pone.0255172https://doaj.org/article/70e651877f644db78bd88a7849765f8a2021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0255172https://doaj.org/toc/1932-6203<h4>Background</h4>Each of the currently available (1→3)-β-D-glucan (BDG) measurement kits follows a different measurement method and cut-off value. Comparisons of diagnostic performance for invasive fungal infections (IFIs) are desirable. Additionally, ecological considerations are becoming increasingly important in the development of new measurement kits.<h4>Methods</h4>The plasma BDG levels in clinical samples were measured using the following currently available kits: the Fungitec G test MKII, the Fungitec G test ES, Fungitell, the β-Glucan test Wako, and the newly developed Wako kit (Wako-Eu). Wako-Eu uses a pre-treatment solution that conforms to European regulations for the registration, evaluation, authorisation, and restriction of chemicals. The values obtained for the samples using each kit were studied and compared.<h4>Results</h4>Of the 165 patients evaluated, 12 had IFIs, including pneumocystis pneumonia, aspergillosis, and candidiasis. BDG values obtained using the kits were moderately correlated with each other. Clinical diagnoses of the evaluated cases indicated that 21 false positives were diagnosed by at least one kit. The sensitivity of the Fungitell kit was relatively low, but those of the other four were over 90%. The specificity was above 90% for all kits. For positive predictive value, the Wako and the Wako-Eu methods were superior to the others owing to fewer false positive results.<h4>Conclusions</h4>The newly developed Wako-Eu method, which considers ecological concerns, shows diagnostic performance equivalent to that of its predecessor. To improve the diagnostic accuracy of IFIs, it is necessary to interpret the results carefully, giving due consideration to the characteristics of each measurement kit.Yuuki BambaKei NaganoHiroshi MoroHideyuki OgataMariko HakamataSatoshi ShibataTakeshi KoizumiNobumasa AokiYasuyoshi OhshimaSatoshi WatanabeTakeshi NakamuraSugako KobayashiYoshiki HoshiyamaToshiyuki KoyaToshinori TakadaToshiaki KikuchiPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 8, p e0255172 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Yuuki Bamba
Kei Nagano
Hiroshi Moro
Hideyuki Ogata
Mariko Hakamata
Satoshi Shibata
Takeshi Koizumi
Nobumasa Aoki
Yasuyoshi Ohshima
Satoshi Watanabe
Takeshi Nakamura
Sugako Kobayashi
Yoshiki Hoshiyama
Toshiyuki Koya
Toshinori Takada
Toshiaki Kikuchi
Efficacy of the new β-D-glucan measurement kit for diagnosing invasive fungal infections, as compared with that of four conventional kits.
description <h4>Background</h4>Each of the currently available (1→3)-β-D-glucan (BDG) measurement kits follows a different measurement method and cut-off value. Comparisons of diagnostic performance for invasive fungal infections (IFIs) are desirable. Additionally, ecological considerations are becoming increasingly important in the development of new measurement kits.<h4>Methods</h4>The plasma BDG levels in clinical samples were measured using the following currently available kits: the Fungitec G test MKII, the Fungitec G test ES, Fungitell, the β-Glucan test Wako, and the newly developed Wako kit (Wako-Eu). Wako-Eu uses a pre-treatment solution that conforms to European regulations for the registration, evaluation, authorisation, and restriction of chemicals. The values obtained for the samples using each kit were studied and compared.<h4>Results</h4>Of the 165 patients evaluated, 12 had IFIs, including pneumocystis pneumonia, aspergillosis, and candidiasis. BDG values obtained using the kits were moderately correlated with each other. Clinical diagnoses of the evaluated cases indicated that 21 false positives were diagnosed by at least one kit. The sensitivity of the Fungitell kit was relatively low, but those of the other four were over 90%. The specificity was above 90% for all kits. For positive predictive value, the Wako and the Wako-Eu methods were superior to the others owing to fewer false positive results.<h4>Conclusions</h4>The newly developed Wako-Eu method, which considers ecological concerns, shows diagnostic performance equivalent to that of its predecessor. To improve the diagnostic accuracy of IFIs, it is necessary to interpret the results carefully, giving due consideration to the characteristics of each measurement kit.
format article
author Yuuki Bamba
Kei Nagano
Hiroshi Moro
Hideyuki Ogata
Mariko Hakamata
Satoshi Shibata
Takeshi Koizumi
Nobumasa Aoki
Yasuyoshi Ohshima
Satoshi Watanabe
Takeshi Nakamura
Sugako Kobayashi
Yoshiki Hoshiyama
Toshiyuki Koya
Toshinori Takada
Toshiaki Kikuchi
author_facet Yuuki Bamba
Kei Nagano
Hiroshi Moro
Hideyuki Ogata
Mariko Hakamata
Satoshi Shibata
Takeshi Koizumi
Nobumasa Aoki
Yasuyoshi Ohshima
Satoshi Watanabe
Takeshi Nakamura
Sugako Kobayashi
Yoshiki Hoshiyama
Toshiyuki Koya
Toshinori Takada
Toshiaki Kikuchi
author_sort Yuuki Bamba
title Efficacy of the new β-D-glucan measurement kit for diagnosing invasive fungal infections, as compared with that of four conventional kits.
title_short Efficacy of the new β-D-glucan measurement kit for diagnosing invasive fungal infections, as compared with that of four conventional kits.
title_full Efficacy of the new β-D-glucan measurement kit for diagnosing invasive fungal infections, as compared with that of four conventional kits.
title_fullStr Efficacy of the new β-D-glucan measurement kit for diagnosing invasive fungal infections, as compared with that of four conventional kits.
title_full_unstemmed Efficacy of the new β-D-glucan measurement kit for diagnosing invasive fungal infections, as compared with that of four conventional kits.
title_sort efficacy of the new β-d-glucan measurement kit for diagnosing invasive fungal infections, as compared with that of four conventional kits.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/70e651877f644db78bd88a7849765f8a
work_keys_str_mv AT yuukibamba efficacyofthenewbdglucanmeasurementkitfordiagnosinginvasivefungalinfectionsascomparedwiththatoffourconventionalkits
AT keinagano efficacyofthenewbdglucanmeasurementkitfordiagnosinginvasivefungalinfectionsascomparedwiththatoffourconventionalkits
AT hiroshimoro efficacyofthenewbdglucanmeasurementkitfordiagnosinginvasivefungalinfectionsascomparedwiththatoffourconventionalkits
AT hideyukiogata efficacyofthenewbdglucanmeasurementkitfordiagnosinginvasivefungalinfectionsascomparedwiththatoffourconventionalkits
AT marikohakamata efficacyofthenewbdglucanmeasurementkitfordiagnosinginvasivefungalinfectionsascomparedwiththatoffourconventionalkits
AT satoshishibata efficacyofthenewbdglucanmeasurementkitfordiagnosinginvasivefungalinfectionsascomparedwiththatoffourconventionalkits
AT takeshikoizumi efficacyofthenewbdglucanmeasurementkitfordiagnosinginvasivefungalinfectionsascomparedwiththatoffourconventionalkits
AT nobumasaaoki efficacyofthenewbdglucanmeasurementkitfordiagnosinginvasivefungalinfectionsascomparedwiththatoffourconventionalkits
AT yasuyoshiohshima efficacyofthenewbdglucanmeasurementkitfordiagnosinginvasivefungalinfectionsascomparedwiththatoffourconventionalkits
AT satoshiwatanabe efficacyofthenewbdglucanmeasurementkitfordiagnosinginvasivefungalinfectionsascomparedwiththatoffourconventionalkits
AT takeshinakamura efficacyofthenewbdglucanmeasurementkitfordiagnosinginvasivefungalinfectionsascomparedwiththatoffourconventionalkits
AT sugakokobayashi efficacyofthenewbdglucanmeasurementkitfordiagnosinginvasivefungalinfectionsascomparedwiththatoffourconventionalkits
AT yoshikihoshiyama efficacyofthenewbdglucanmeasurementkitfordiagnosinginvasivefungalinfectionsascomparedwiththatoffourconventionalkits
AT toshiyukikoya efficacyofthenewbdglucanmeasurementkitfordiagnosinginvasivefungalinfectionsascomparedwiththatoffourconventionalkits
AT toshinoritakada efficacyofthenewbdglucanmeasurementkitfordiagnosinginvasivefungalinfectionsascomparedwiththatoffourconventionalkits
AT toshiakikikuchi efficacyofthenewbdglucanmeasurementkitfordiagnosinginvasivefungalinfectionsascomparedwiththatoffourconventionalkits
_version_ 1718374651726397440